Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Leukemia, Myeloid, Acute 138Precursor Cell Lymphoblastic Leukemia-Lymphoma 137Leukemia 134Lymphoma 130Lymphoma, Non-Hodgkin 124Multiple Myeloma 117Leukemia, Lymphocytic, Chronic, B-Cell 116Lymphoma, Follicular 115Lymphoma, Large B-Cell, Diffuse 114Hodgkin Disease 107Lymphoma, Mantle-Cell 103Myelodysplastic Syndromes 99Lymphoma, Large-Cell, Immunoblastic 96Burkitt Lymphoma 94Lymphoma, B-Cell, Marginal Zone 81Leukemia, Myeloid, Chronic-Phase 76Congenital Abnormalities 76Leukemia, Myeloid, Accelerated Phase 74Myeloproliferative Disorders 71Neoplasms, Plasma Cell 64Leukemia, Myelomonocytic, Chronic 63Blast Crisis 58Waldenstrom Macroglobulinemia 52Recurrence 47Breast Neoplasms 45Primary Myelofibrosis 44Lymphoma, T-Cell, Cutaneous 43Sezary Syndrome 39Mycosis Fungoides 39Anemia, Refractory, with Excess of Blasts 39

Interventions

fludarabine phosphate 7fludarabine 6Cyclophosphamide 5Whole-Body Irradiation 4Busulfan 4Antilymphocyte Serum 4Alemtuzumab 3Thiotepa 2Tacrolimus 2Peripheral Blood Stem Cell Transplantation 2Mycophenolic Acid 2Melphalan 2Clofarabine 2Bone Marrow Transplantation 2treosulfan 1thymoglobulin 1posaconazole 1eltrombopag 1X-Rays 1Therapeutics 1Specimen Handling 1Sirolimus 1Passive Cutaneous Anaphylaxis 1Morphine 1Methylprednisolone Hemisuccinate 1Methylprednisolone 1Methotrexate 1Methadone 1Hydromorphone 1Genetic Counseling 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Bone Marrow Failure Disorders × Peripheral Blood Stem Cell Transplantation × Clear all
NCT04965597 2026-03-09

Treosulfan-Based Conditioning Regimen Before a Blood or Bone Marrow Transplant for the Treatment of Bone Marrow Failure Diseases (BMT CTN 1904)

Fred Hutchinson Cancer Center

Phase 2 Completed
40 enrolled
Classical hematology

Congenital amegakaryocytic thrombocytopenia, Bone Marrow Failure Disorders, Shwachman-Diamond Syndrome, Anemia, Hypochromic, Hemoglobinuria, Paroxysmal, Anemia, Diamond-Blackfan

NCT03622788 2025-12-17

Cytokine-Treated Veto Cells in Treating Patients With Hematologic Malignancies Following Stem Cell Transplant

M.D. Anderson Cancer Center

Phase 1/2 Active not recruiting
16 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Bone Marrow Failure Disorders, Anemia, Aplastic, Hodgkin Disease, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡